NTRA
Price
$289.92Alerts
Change
+$0.42 (+0.15%)
Updated
Nov 19 closing price
Capitalization
44.78B
105 days until earnings call
Intraday BUY SELL Signals
RCEL
Price
$15.99Alerts
Change
-$0.84 (-4.99%)
Updated
Nov 19 closing price
Capitalization
513.08M
98 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

NTRA vs RCEL

NTRA vs RCEL Comparison Chart in %
View a ticker or compare two or three
VS
NTRA vs. RCEL commentary
Nov 20, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NTRA is a Hold and RCEL is a Buy.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for NTRA with price predictions
Nov 18, 2026

NTRA in downward trend: 10-day moving average broke below 50-day moving average on November 10, 2026

The 10-day moving average for NTRA crossed bearishly below the 50-day moving average on November 10, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 10 of 13 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 77%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 02, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on NTRA as a result. In 66 of 96 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 69%.

The Moving Average Convergence Divergence Histogram (MACD) for NTRA turned negative on October 30, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 49 similar instances when the indicator turned negative. In 30 of the 49 cases the stock turned lower in the days that followed. This puts the odds of success at 61%.

NTRA moved below its 50-day moving average on November 05, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where NTRA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 75%.

The Aroon Indicator for NTRA entered a downward trend on November 10, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 11 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +3.51% 3-day Advance, the price is estimated to grow further. Considering data from situations where NTRA advanced for three days, in 246 of 307 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.

NTRA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 4 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (24.585) is normal, around the industry mean (67.298). NTRA's P/E Ratio (-230.126) is considerably lower than the industry average of (4.239). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.473). Dividend Yield (0.000) settles around the average of (0.002) among similar stocks. P/S Ratio (17.857) is also within normal values, averaging (9.775).

The Tickeron Profit vs. Risk Rating rating for this company is 35 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 87, placing this stock slightly better than average.

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is 56 (best 1 - 100 worst), indicating fairly steady price growth. NTRA’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 71 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 94 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

A.I.Advisor
a Summary for RCEL with price predictions
Nov 19, 2026

Aroon Indicator for RCEL shows an upward move is likely

RCEL's Aroon Indicator triggered a bullish signal on November 18, 2026. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 183 similar instances where the Aroon Indicator showed a similar pattern. In 165 of the 183 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 52 of 67 cases where RCEL's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 78%.

The Momentum Indicator moved above the 0 level on November 17, 2026. You may want to consider a long position or call options on RCEL as a result. In 80 of 98 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 82%.

Following a +10.58% 3-day Advance, the price is estimated to grow further. Considering data from situations where RCEL advanced for three days, in 221 of 280 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.

Bearish Trend Analysis

The 10-day RSI Indicator for RCEL moved out of overbought territory on November 11, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 31 similar instances where the indicator moved out of overbought territory. In 24 of the 31 cases, the stock moved lower in the following days. This puts the odds of a move lower at 77%.

The Moving Average Convergence Divergence Histogram (MACD) for RCEL turned negative on November 12, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 51 similar instances when the indicator turned negative. In 42 of the 51 cases the stock turned lower in the days that followed. This puts the odds of success at 82%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where RCEL declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 80%.

RCEL broke above its upper Bollinger Band on November 10, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 16 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: RCEL's P/B Ratio (-18.431) is slightly lower than the industry average of (4.142). P/E Ratio (-11.521) is within average values for comparable stocks, (3.291). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (11.253). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (4.136) is also within normal values, averaging (40.124).

The Tickeron Price Growth Rating for this company is 34 (best 1 - 100 worst), indicating steady price growth. RCEL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron PE Growth Rating for this company is 98 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. RCEL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

FUNDAMENTALS RATINGS
NTRA vs RCEL: Fundamental Ratings
NTRA
RCEL
OUTLOOK RATING
1..100
8485
VALUATION
overvalued / fair valued / undervalued
1..100
4
Undervalued
16
Undervalued
PROFIT vs RISK RATING
1..100
35100
SMR RATING
1..100
94100
PRICE GROWTH RATING
1..100
5634
P/E GROWTH RATING
1..100
7198
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NTRA's Valuation (4) in the Biotechnology industry is in the same range as RCEL (16) in the null industry. This means that NTRA’s stock grew similarly to RCEL’s over the last 12 months.

NTRA's Profit vs Risk Rating (35) in the Biotechnology industry is somewhat better than the same rating for RCEL (100) in the null industry. This means that NTRA’s stock grew somewhat faster than RCEL’s over the last 12 months.

NTRA's SMR Rating (94) in the Biotechnology industry is in the same range as RCEL (100) in the null industry. This means that NTRA’s stock grew similarly to RCEL’s over the last 12 months.

RCEL's Price Growth Rating (34) in the null industry is in the same range as NTRA (56) in the Biotechnology industry. This means that RCEL’s stock grew similarly to NTRA’s over the last 12 months.

NTRA's P/E Growth Rating (71) in the Biotechnology industry is in the same range as RCEL (98) in the null industry. This means that NTRA’s stock grew similarly to RCEL’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
NTRARCEL
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 1 day ago
77%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 1 day ago
78%
Momentum
ODDS (%)
Bearish Trend 2 days ago
69%
Bullish Trend 1 day ago
82%
MACD
ODDS (%)
Bearish Trend 2 days ago
61%
Bearish Trend 1 day ago
82%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
76%
Bearish Trend 1 day ago
82%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
78%
Bullish Trend 1 day ago
85%
Advances
ODDS (%)
Bullish Trend 8 days ago
80%
Bullish Trend 2 days ago
79%
Declines
ODDS (%)
Bearish Trend 3 days ago
75%
Bearish Trend 4 days ago
80%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 1 day ago
84%
Aroon
ODDS (%)
Bearish Trend 2 days ago
76%
Bullish Trend 1 day ago
90%
COMPARISON
Comparison
Nov 20, 2026
Stock price -- (NTRA: $289.50 vs. RCEL: $16.83)
Brand notoriety: NTRA and RCEL are both not notable
NTRA represents the Medical Specialties, while RCEL is part of the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: NTRA: 112% vs. RCEL: 136%
Market capitalization -- NTRA: $44.78B vs. RCEL: $513.08M
NTRA [@Medical Specialties] is valued at $44.78B. RCEL’s [@Medical/Nursing Services] market capitalization is $513.08M. The market cap for tickers in the [@Medical Specialties] industry ranges from $27 to $4.39T. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $837 to $190.22B. The average market capitalization across the [@Medical Specialties] industry is $20.94B. The average market capitalization across the [@Medical/Nursing Services] industry is $6.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NTRA’s FA Score shows that 1 FA rating(s) are green while RCEL’s FA Score has 1 green FA rating(s).

  • NTRA’s FA Score: 1 green, 4 red.
  • RCEL’s FA Score: 1 green, 4 red.
According to our system of comparison, NTRA is a better buy in the long-term than RCEL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NTRA’s TA Score shows that 4 TA indicator(s) are bullish while RCEL’s TA Score has 4 bullish TA indicator(s).

  • NTRA’s TA Score: 4 bullish, 6 bearish.
  • RCEL’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, RCEL is a better buy in the short-term than NTRA.

Price Growth

NTRA (@Medical Specialties) experienced а -9.48% price change this week, while RCEL (@Medical/Nursing Services) price change was -2.72% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -8.36%. For the same industry, the average monthly price growth was -12.97%, and the average quarterly price growth was +19.50%.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -9.30%. For the same industry, the average monthly price growth was -12.27%, and the average quarterly price growth was -15.98%.

Reported Earning Dates

NTRA is expected to report earnings on Mar 04, 2027.

RCEL is expected to report earnings on Feb 25, 2027.

Industries' Descriptions

@Medical Specialties (-8.36% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

@Medical/Nursing Services (-9.30% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

View a ticker or compare two or three
Interact to see
Advertisement

NTRA and

Correlation & Price change

A.I.dvisor indicates that over the last year, NTRA has been loosely correlated with GH. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if NTRA jumps, then GH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NTRA
1D Price
Change %
NTRA100%
+0.15%
GH - NTRA
60%
Loosely correlated
+0.31%
NEO - NTRA
53%
Loosely correlated
-1.31%
ISRG - NTRA
53%
Loosely correlated
-3.26%
ADPT - NTRA
52%
Loosely correlated
-1.44%
TMO - NTRA
50%
Loosely correlated
-0.58%
More

RCEL and

Correlation & Price change

A.I.dvisor indicates that over the last year, RCEL has been loosely correlated with SENS. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if RCEL jumps, then SENS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RCEL
1D Price
Change %
RCEL100%
-4.99%
SENS - RCEL
45%
Loosely correlated
-8.57%
NTRA - RCEL
30%
Poorly correlated
+0.15%
VCYT - RCEL
29%
Poorly correlated
-2.07%
TWST - RCEL
29%
Poorly correlated
-4.07%
STXS - RCEL
29%
Poorly correlated
+6.75%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PTLE9.00N/A
N/A
PTL Ltd
NTST18.49-0.06
-0.32%
NetSTREIT Corp
FDBC65.23-0.76
-1.15%
Fidelity D & D Bancorp
AMG378.29-14.34
-3.65%
Affiliated Managers Group
JAGX0.33-0.03
-7.42%
Jaguar Health Inc